Federal Register Notice: FDA is seeking public comment on the collection of information contained in the guidance Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions dated 3/18/02. The guidance gives recommendations for IND sponsors on submitting information about clinical trials for serious or life- threatening diseases to a Clinical Trials Data Bank developed by the National Library of Medicine, National Institutes of Health. The guidance covers mandatory and voluntary submissions, and certifications. Comments should be submitted by 7/13. To view this notice, click here.